South Korea Pharmaceuticals and Healthcare Report - Business Monitor International - Industry Reports

South Korea Pharmaceuticals and Healthcare Report

South Korea Pharmaceuticals and Healthcare Report - Business Monitor International - Industry Reports
South Korea Pharmaceuticals and Healthcare Report
Published Oct 15, 2016
112 pages — Published Oct 15, 2016
Price US$ 1,295.00  |  Buy this Report Now

About This Report

  
Abstract:

In July ----, Hanmi Pharmaceutical President Lee Gwan-sun noted that the firm is embarking on a research strategy that will reduce the emphasis on generics and shift towards a specialisation in branded medicines. Lee also disclosed that the company has a pipeline of -- new drug candidates and that it devotes the bulk of its research spending into the areas of autoimmune diseases, diabetes and cancer. ...In July ----, Hanmi Pharmaceutical President Lee Gwan-sun noted that the firm is embarking on a research strategy that will reduce the emphasis on generics and shift towards a specialisation in branded medicines. Lee also disclosed that the company has a pipeline of -- new drug candidates and that it devotes the bulk of its research spending into the areas of autoimmune diseases, diabetes and cancer. That same month, South Korea confirmed its ninth case of Zika infection. ...A total of -- people have been implicated in the case, including Novartis Korea chief executive Moon Hak-sun. According to the prosecutors, Moon tried to go around laws by funding academic events organised by publishers of medical journals where the invited doctors allegedly received kickbacks presented as attendance fees.

...Government and industry support for biotechnology research. Capitalising on the current positive results achieved by some domestic firms, following their R&D investments. Population ageing promoting the growth of long-term and chronic disease segments, as well as the medical devices market. The implementation of the FTA with the US to improve intellectual property (IP) environment and trade regimes for research-based companies. Cough drops and pain killers can now be sold at ---hour convenience stores, providing an upside risk to OTC drug market. ...Cough drops and pain killers can now be sold at ---hour convenience stores, providing an upside risk to OTC drug market. Despite being unpopular with the public, plans to liberalise health insurance are providing stimulus for pharmaceuticals market growth.

...� Business Monitor International Ltd Page - Pharmaceutical SWOT Analysis - Continued The government s resistance to aligning domestic patent law fully with international standards is hampering multinational activity. FTA with the US to widen pharmaceuticals trade deficit. ...

  
Source:
Document ID
1748-2208
Country
Industry
Format:
PDF Adobe Acrobat
Buy Now

Business Monitor International - Industry Reports—Established in 1984, Business Monitor International is a leading online publisher of specialist business information on global emerging markets. Business Monitor's range of quarterly services covers political risk, finance, macroeconomic performance, outlook and forecast, industry sectors and the business operating environment. Each Industry Report has been researched at source, and features latest-available data covering production, sales, imports and exports; 5-year industry forecasts through end-2012; company rankings and competitive landscapes for multinational and local manufacturers and suppliers; and analysis of latest industry developments, trends and regulatory changes.

About the Author


Cite this Report

  
MLA:
Business Monitor International - Industry Reports. "South Korea Pharmaceuticals and Healthcare Report" Oct 15, 2016. Alacra Store. Dec 09, 2016. <http://www.alacrastore.com/storecontent/Business-Monitor-International-Industry-Reports/South-Korea-Pharmaceuticals-and-Healthcare-Report-2026-121>
  
APA:
Business Monitor International - Industry Reports. (2016). South Korea Pharmaceuticals and Healthcare Report Oct 15, 2016. New York, NY: Alacra Store. Retrieved Dec 09, 2016 from <http://www.alacrastore.com/storecontent/Business-Monitor-International-Industry-Reports/South-Korea-Pharmaceuticals-and-Healthcare-Report-2026-121>
  
US$ 1,295.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Market Research from one place.